NetraMark Holdings (AIAI) Stock Overview
Develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
AIAI Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
NetraMark Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.39 |
| 52 Week High | CA$1.79 |
| 52 Week Low | CA$0.15 |
| Beta | 1.81 |
| 1 Month Change | 12.10% |
| 3 Month Change | -1.42% |
| 1 Year Change | 456.00% |
| 3 Year Change | 321.21% |
| 5 Year Change | n/a |
| Change since IPO | -22.78% |
Recent News & Updates
Shareholder Returns
| AIAI | CA Healthcare Services | CA Market | |
|---|---|---|---|
| 7D | 3.0% | 2.1% | 0.9% |
| 1Y | 456.0% | 50.6% | 16.9% |
Return vs Industry: AIAI exceeded the Canadian Healthcare Services industry which returned 49.7% over the past year.
Return vs Market: AIAI exceeded the Canadian Market which returned 15.5% over the past year.
Price Volatility
| AIAI volatility | |
|---|---|
| AIAI Average Weekly Movement | 13.1% |
| Healthcare Services Industry Average Movement | 12.5% |
| Market Average Movement | 9.7% |
| 10% most volatile stocks in CA Market | 18.5% |
| 10% least volatile stocks in CA Market | 3.9% |
Stable Share Price: AIAI has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: AIAI's weekly volatility (13%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | George Achilleos | www.netramark.com |
NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. The company’s product suite comprises Netra Shatter; Netra Health Atlas; and NetraAi that is designed to help interact and explore with different perspective of the data for clinical trials. It provides NetraPlacebo module that analyzes past trial data to determine what drives placebo responses to guide inclusion/exclusion criteria; and Netra GPT module that offers insights from past clinical trials about the patient’s population by utilizing established medical literature.
NetraMark Holdings Inc. Fundamentals Summary
| AIAI fundamental statistics | |
|---|---|
| Market cap | CA$114.72m |
| Earnings (TTM) | -CA$4.09m |
| Revenue (TTM) | CA$620.36k |
Is AIAI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AIAI income statement (TTM) | |
|---|---|
| Revenue | CA$620.36k |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$620.36k |
| Other Expenses | CA$4.71m |
| Earnings | -CA$4.09m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.051 |
| Gross Margin | 100.00% |
| Net Profit Margin | -658.73% |
| Debt/Equity Ratio | 0% |
How did AIAI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/06 19:34 |
| End of Day Share Price | 2025/06/06 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
NetraMark Holdings Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.